These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19039061)

  • 21. [Investigation of Chlamydophila pneumoniae seropositivity and risk factors in patients with atherosclerotic vascular disease in Sivas, Turkey].
    Kılıç ZB; Poyraz O; Kılıç AT
    Mikrobiyol Bul; 2012 Jan; 46(1):156-8. PubMed ID: 22399186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis.
    Yavuz MT; Yavuz O; Yazici M; Guler S; Ozhan H; Albayrak S; Coskun A
    Scand J Clin Lab Invest; 2006; 66(6):523-34. PubMed ID: 17000560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of chlamydia pneumoniae antibodies in patients with coronary heart disease].
    Podsiadły E; Kruk M; Przyłuski J; Deptuch T; Ruzyłło W; Tylewska-Wierzbanowska S
    Przegl Epidemiol; 2001; 55(3):253-60. PubMed ID: 11761832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel enzyme immunoassay utilizing lipopolysaccharide-binding protein as a capture molecule for the measurement of chlamydial lipopolysaccharide in serum.
    Tiirola T; Jaakkola A; Bloigu A; Paldanius M; Sinisalo J; Nieminen MS; Silvennoinen-Kassinen S; Saikku P; Jauhiainen M; Leinonen M
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):7-12. PubMed ID: 16290027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases.
    Romano Carratelli C; Nuzzo I; Cozzolino D; Bentivoglio C; Paolillo R; Rizzo A
    Int Immunopharmacol; 2006 May; 6(5):848-53. PubMed ID: 16546716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of Chlamydia pneumoniae infection in patients with coronary artery disease subjected to angioplasty or bypass surgery.
    Pieniazek P; Karczewska E; Stepień E; Tracz W; Konturek SJ
    Med Sci Monit; 2001; 7(5):995-1001. PubMed ID: 11535948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease.
    Kaperonis EA; Liapis CD; Kakisis JD; Dimitroulis D; Papavassiliou VG; Perrea D; Kostakis AG
    Eur J Vasc Endovasc Surg; 2006 May; 31(5):509-15. PubMed ID: 16427340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlamydia pneumoniae immunoreactivity in coronary artery plaques of patients with acute coronary syndromes and its relation with serology.
    Liu R; Yamamoto M; Moroi M; Kubota T; Ono T; Funatsu A; Komatsu H; Tsuji T; Hara H; Hara H; Nakamura M; Hirai H; Yamaguchi T
    Am Heart J; 2005 Oct; 150(4):681-8. PubMed ID: 16209964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of carotid plaque inflammation and Chlamydia pneumoniae infection with cerebrovascular symptomatology.
    Kaperonis EA; Liapis CD; Kakisis JD; Perrea D; Kostakis AG; Karayannakos PE
    J Vasc Surg; 2006 Dec; 44(6):1198-204. PubMed ID: 17145421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum chlamydial lipopolysaccharide as a prognostic factor for a new cardiovascular event.
    Pesonen E; Tiirola T; Andsberg E; Jauhiainen M; Paldanius M; Persson K; Saikku P; Sarna S; Ohlin H; Leinonen M
    Heart Lung; 2009; 38(3):176-81. PubMed ID: 19486785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunofluorescence in situ and the serologic indices of Chlamydia pneumoniae infection in patients with an abdominal aortic aneurysm.
    Wolski A; Korobowicz E; Siezieniewska Z; Mazur E; Niedźwiadek J; Kozioł-Montewka M; Michalak J
    Pol J Pathol; 2002; 53(4):223-8. PubMed ID: 12597340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum.
    Palikhe A; Tiirola T; Puolakkainen M; Nieminen MS; Saikku P; Leinonen M; Sinisalo J
    Scand J Infect Dis; 2009; 41(3):201-5. PubMed ID: 19172436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects.
    Hashimoto I; Wada J; Hida A; Baba M; Miyatake N; Eguchi J; Shikata K; Makino H
    Obesity (Silver Spring); 2006 May; 14(5):799-811. PubMed ID: 16855189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the United States military: the importance of timing of exposure measurement.
    Arcari CM; Gaydos CA; Nieto FJ; Krauss M; Nelson KE
    Clin Infect Dis; 2005 Apr; 40(8):1123-30. PubMed ID: 15791511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relation between Chlamydia pneumoniae infection and abdominal aortic aneurysm].
    Wolski A; Mazur E; Niedźwiadek J; Slepko J; Kozioł-Montewka M; Michalak J
    Pol Merkur Lekarski; 2001 Dec; 11(66):491-4. PubMed ID: 11899845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease.
    Sessa R; Di Pietro M; Schiavoni G; Santino I; Benedetti-Valentini F; Perna R; Romano S; del Piano M
    J Vasc Surg; 2003 May; 37(5):1027-31. PubMed ID: 12756349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart disease.
    Schumacher A; Seljeflot I; Lerkerød AB; Sommervoll L; Otterstad JE; Arnesen H
    Eur J Clin Invest; 2005 Jul; 35(7):431-7. PubMed ID: 16008544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Close association of Chlamydia pneumoniae IgA seropositivity by ELISA with the presence of coronary artery stenosis in haemodialysis patients.
    Nishimura M; Hashimoto T; Kobayashi H; Fukuda T; Okino K; Yamamoto N; Mashida C; Kawagoe K; Fujita H; Inoue N; Takahashi H; Ono T
    Nephrol Dial Transplant; 2005 Sep; 20(9):1944-50. PubMed ID: 15956072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of human monocyte-macrophages to Chlamydia pneumoniae infection in vitro is highly variable and associated with levels of soluble CD14 and C. pneumoniae IgA and human HSP-IgG antibodies in serum.
    Poikonen K; Lajunen T; Silvennoinen-Kassinen S; Paldanius M; Leinonen M; Saikku P
    Scand J Immunol; 2008 Mar; 67(3):279-84. PubMed ID: 18194359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
    Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
    Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.